ArticleJournal for immunotherapy of cancer2026

Tumor cell-expressed OX40L enhances the efficacy of PD-1 axis blockade in non-small cell lung cancer.

Carmen Fernández-Luna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.